The effect of APOE genotype on clinical phenotype in Alzheimer disease

W. M. Van Der Flier; S. N.M. Schoonenboom; Y. A.L. Pijnenburg; N. C. Fox; P. Scheltens

doi:10.1212/01.wnl.0000228222.17111.2a

The effect of APOE genotype on clinical phenotype in Alzheimer disease

W. M. Van Der Flier^*, S. N.M. Schoonenboom, Y. A.L. Pijnenburg, N. C. Fox, P. Scheltens

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

The authors classified 100 patients with Alzheimer disease (AD) as presenting with a memory or nonmemory phenotype. APOE genotype was determined. There was an association between APOE-ε4 and clinical phenotype (odds ratio = 3.0; 95% CI: 1.2 to 7.8), suggesting that two subtypes of AD can be identified. The typical amnestic phenotype seems to be promoted by the APOE-ε4 allele, whereas the atypical nonmemory phenotype occurs in the absence of the APOE-ε4 allele.

Original language	English
Pages (from-to)	526-527
Number of pages	2
Journal	Neurology
Volume	67
Issue number	3
DOIs	https://doi.org/10.1212/01.wnl.0000228222.17111.2a
Publication status	Published - 1 Aug 2006

Access to Document

10.1212/01.wnl.0000228222.17111.2a

Link to publication in Scopus

Cite this

Van Der Flier, W. M., Schoonenboom, S. N. M., Pijnenburg, Y. A. L., Fox, N. C., & Scheltens, P. (2006). The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology, 67(3), 526-527. https://doi.org/10.1212/01.wnl.0000228222.17111.2a

@article{e14c751d96154e248c5c17b4e88dd76f,

title = "The effect of APOE genotype on clinical phenotype in Alzheimer disease",

abstract = "The authors classified 100 patients with Alzheimer disease (AD) as presenting with a memory or nonmemory phenotype. APOE genotype was determined. There was an association between APOE-ε4 and clinical phenotype (odds ratio = 3.0; 95{\%} CI: 1.2 to 7.8), suggesting that two subtypes of AD can be identified. The typical amnestic phenotype seems to be promoted by the APOE-ε4 allele, whereas the atypical nonmemory phenotype occurs in the absence of the APOE-ε4 allele.",

author = "{Van Der Flier}, {W. M.} and Schoonenboom, {S. N.M.} and Pijnenburg, {Y. A.L.} and Fox, {N. C.} and P. Scheltens",

year = "2006",

month = "8",

day = "1",

doi = "10.1212/01.wnl.0000228222.17111.2a",

language = "English",

volume = "67",

pages = "526--527",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "3",

}

TY - JOUR

T1 - The effect of APOE genotype on clinical phenotype in Alzheimer disease

AU - Van Der Flier, W. M.

AU - Schoonenboom, S. N.M.

AU - Pijnenburg, Y. A.L.

AU - Fox, N. C.

AU - Scheltens, P.

PY - 2006/8/1

Y1 - 2006/8/1

N2 - The authors classified 100 patients with Alzheimer disease (AD) as presenting with a memory or nonmemory phenotype. APOE genotype was determined. There was an association between APOE-ε4 and clinical phenotype (odds ratio = 3.0; 95% CI: 1.2 to 7.8), suggesting that two subtypes of AD can be identified. The typical amnestic phenotype seems to be promoted by the APOE-ε4 allele, whereas the atypical nonmemory phenotype occurs in the absence of the APOE-ε4 allele.

AB - The authors classified 100 patients with Alzheimer disease (AD) as presenting with a memory or nonmemory phenotype. APOE genotype was determined. There was an association between APOE-ε4 and clinical phenotype (odds ratio = 3.0; 95% CI: 1.2 to 7.8), suggesting that two subtypes of AD can be identified. The typical amnestic phenotype seems to be promoted by the APOE-ε4 allele, whereas the atypical nonmemory phenotype occurs in the absence of the APOE-ε4 allele.

UR - http://www.scopus.com/inward/record.url?scp=33747059031&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000228222.17111.2a

DO - 10.1212/01.wnl.0000228222.17111.2a

M3 - Article

C2 - 16894123

AN - SCOPUS:33747059031

VL - 67

SP - 526

EP - 527

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 3

ER -